CLINICAL_TRIALS
trial_result
· 2014-09-03
Clinical Trial Update: Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer [Phase 3]
Summary
Phase 3 clinical trial results update on intermittent degarelix treatment for prostate cancer; the study is completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2014-09-03